Literature DB >> 22348520

Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations.

Kazuyuki Matsuda, Nao Yoshida, Shuhei Miura, Yozo Nakazawa, Kazuo Sakashita, Nobuyuki Hyakuna, Masahiro Saito, Fumiyo Kato, Atsushi Ogawa, Akihiro Watanabe, Manabu Sotomatsu, Chie Kobayashi, Toshiro Ito, Fumihiro Ishida, Atsushi Manabe, Seiji Kojima, Kenichi Koike.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22348520     DOI： 10.1111/j.1365-2141.2012.09063.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.

Authors:  Katherine R Calvo; Susan Price; Raul C Braylan; Joao Bosco Oliveira; Michael Lenardo; Thomas A Fleisher; V Koneti Rao
Journal:  Blood       Date:  2015-02-17       Impact factor: 22.113

2.  Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan.

Authors:  Miharu Yabe; Yoshitoshi Ohtsuka; Kenichiro Watanabe; Jiro Inagaki; Nao Yoshida; Kazuo Sakashita; Harumi Kakuda; Hiromasa Yabe; Hidemitsu Kurosawa; Kazuko Kudo; Atsushi Manabe
Journal:  Int J Hematol       Date:  2014-12-11       Impact factor: 2.490

3.  In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.

Authors:  K Sakashita; I Kato; T Daifu; S Saida; H Hiramatsu; Y Nishinaka; Y Ebihara; F Ma; K Matsuda; S Saito; K Hirabayashi; T Kurata; L T N Uyen; Y Nakazawa; K Tsuji; T Heike; T Nakahata; K Koike
Journal:  Leukemia       Date:  2014-08-08       Impact factor: 11.528

Review 4.  The spliceosome as a target of novel antitumour drugs.

Authors:  Sophie Bonnal; Luisa Vigevani; Juan Valcárcel
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

5.  Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.

Authors:  Yozo Nakazawa; Kazuyuki Matsuda; Takashi Kurata; Akane Sueki; Miyuki Tanaka; Kazuo Sakashita; Chihaya Imai; Matthew H Wilson; Kenichi Koike
Journal:  J Hematol Oncol       Date:  2016-03-16       Impact factor: 17.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.